SMAD3 and acute myeloid leukemia: Several leukaemia-associated oncogenes, EVI1, RUNX1-EVI1 and RUNX1-ETO, interact with Smad3 to repress TGFβ signaling in AML and chronic myeloid leukaemia23–25.